-
2
-
-
0034712536
-
Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: A multicentre randomised trial
-
Douillard JY, Cunningham D, Roth AD, et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 2000;355:1041-1047
-
(2000)
Lancet
, vol.355
, pp. 1041-1047
-
-
Douillard, J.Y.1
Cunningham, D.2
Roth, A.D.3
-
3
-
-
0033874892
-
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer
-
De Gramont A, Figer A, Seymour M, et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 2000;18:2938-2947
-
(2000)
J Clin Oncol
, vol.18
, pp. 2938-2947
-
-
De Gramont, A.1
Figer, A.2
Seymour, M.3
-
4
-
-
2542561964
-
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
-
Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004;350:2335-2342
-
(2004)
N Engl J Med
, vol.350
, pp. 2335-2342
-
-
Hurwitz, H.1
Fehrenbacher, L.2
Novotny, W.3
-
5
-
-
3242720345
-
Cetuximab monotherapy and cetuximab plus irinotecan in irinotecanrefractory metastatic colorectal cancer
-
Cunningham D, Humblet Y, Siena S, et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecanrefractory metastatic colorectal cancer. N Engl J Med 2004; 351:337-345
-
(2004)
N Engl J Med
, vol.351
, pp. 337-345
-
-
Cunningham, D.1
Humblet, Y.2
Siena, S.3
-
6
-
-
4644320061
-
Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: A model to predict long-term survival
-
Adam R, Delvart V, Pascal G, et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 2004;240:644-657
-
(2004)
Ann Surg
, vol.240
, pp. 644-657
-
-
Adam, R.1
Delvart, V.2
Pascal, G.3
-
7
-
-
15744374738
-
Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma
-
Leonard GD, Brenner B, Kemeny NE. Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma. J Clin Oncol 2005; 23:2038-2048
-
(2005)
J Clin Oncol
, vol.23
, pp. 2038-2048
-
-
Leonard, G.D.1
Brenner, B.2
Kemeny, N.E.3
-
8
-
-
34548513652
-
Final results of the EORTC Intergroup randomized phase III study 40983 [EPOC] evaluating the benefit of peri-operative FOLFOX4 chemotherapy for patients with potentially resectable colorectal cancer liver metastases
-
Nordlinger B, Sorbye H, Collette B, et al. Final results of the EORTC Intergroup randomized phase III study 40983 [EPOC] evaluating the benefit of peri-operative FOLFOX4 chemotherapy for patients with potentially resectable colorectal cancer liver metastases. 2007 ASCO Annual Meeting Proceedings Part I. Journal of Clinical Oncology 2007;25(18 suppl)
-
(2007)
ASCO Annual Meeting Proceedings Part I. Journal of Clinical Oncology 2007;25(18 suppl)
-
-
Nordlinger, B.1
Sorbye, H.2
Collette, B.3
-
9
-
-
10044266415
-
A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases
-
Jaeck D, Oussoultzoglou E, Rosso E, et al. A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg 2004;240:1037-1049
-
(2004)
Ann Surg
, vol.240
, pp. 1037-1049
-
-
Jaeck, D.1
Oussoultzoglou, E.2
Rosso, E.3
-
10
-
-
0037635260
-
Right portal vein ligation: A new planned two-step all-surgical approach for complete resection of primary gastrointestinal tumors with multiple bilateral liver metastases
-
Kianmanesh R, Farges O, Abdalla EK, et al. Right portal vein ligation: a new planned two-step all-surgical approach for complete resection of primary gastrointestinal tumors with multiple bilateral liver metastases. J Am Coll Surg 2003; 197:164-170
-
(2003)
J Am Coll Surg
, vol.197
, pp. 164-170
-
-
Kianmanesh, R.1
Farges, O.2
Abdalla, E.K.3
-
11
-
-
0037315694
-
Portal vein embolization before right hepatectomy: Prospective clinical trial
-
Farges O, Belghiti J, Kianmanesh R, et al. Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg 2003;237:208-217
-
(2003)
Ann Surg
, vol.237
, pp. 208-217
-
-
Farges, O.1
Belghiti, J.2
Kianmanesh, R.3
-
12
-
-
0033658667
-
Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors
-
Adam R, Laurent A, Azoulay D, et al. Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors. Ann Surg 2000;232:777-785
-
(2000)
Ann Surg
, vol.232
, pp. 777-785
-
-
Adam, R.1
Laurent, A.2
Azoulay, D.3
-
13
-
-
0036269410
-
Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization
-
Abdalla EK, Barnett CC, Doherty D, et al. Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization. Arch Surg 2002;137:675-680
-
(2002)
Arch Surg
, vol.137
, pp. 675-680
-
-
Abdalla, E.K.1
Barnett, C.C.2
Doherty, D.3
-
14
-
-
33947267189
-
Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases
-
Zorzi D, Laurent A, Pawlik TM, et al. Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases. Br J Surg 2007;94:274-286
-
(2007)
Br J Surg
, vol.94
, pp. 274-286
-
-
Zorzi, D.1
Laurent, A.2
Pawlik, T.M.3
-
15
-
-
11144354740
-
Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer
-
Rubbia-Brandt L, Audard V, Sartoretti P, et al. Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 2004;15:460-466
-
(2004)
Ann Oncol
, vol.15
, pp. 460-466
-
-
Rubbia-Brandt, L.1
Audard, V.2
Sartoretti, P.3
-
16
-
-
19744365905
-
Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases
-
Fernandez FG, Ritter J, Goodwin JW, et al. Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases. J Am Coll Surg 2005;200:845-853
-
(2005)
J Am Coll Surg
, vol.200
, pp. 845-853
-
-
Fernandez, F.G.1
Ritter, J.2
Goodwin, J.W.3
-
17
-
-
30144435398
-
Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases
-
Karoui M, Penna C, Amin-Hashem M, et al. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 2006;243:1-7
-
(2006)
Ann Surg
, vol.243
, pp. 1-7
-
-
Karoui, M.1
Penna, C.2
Amin-Hashem, M.3
-
18
-
-
33646457231
-
Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases
-
Vauthey JN, Pawlik TM, Ribero D, et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 2006;24:2065-2072
-
(2006)
J Clin Oncol
, vol.24
, pp. 2065-2072
-
-
Vauthey, J.N.1
Pawlik, T.M.2
Ribero, D.3
-
19
-
-
33745298640
-
Portal vein embolisation prior to hepatic resection for colorectal liver metastases and the effects of periprocedure chemotherapy
-
Beal IK, Anthony S, Papadopoulou A, et al. Portal vein embolisation prior to hepatic resection for colorectal liver metastases and the effects of periprocedure chemotherapy. Br J Radiol 2006;79:473-478
-
(2006)
Br J Radiol
, vol.79
, pp. 473-478
-
-
Beal, I.K.1
Anthony, S.2
Papadopoulou, A.3
-
20
-
-
33644504569
-
Chemotherapy does not impair hypertrophy of the left liver after right portal vein obstruction
-
Goere D, Farges O, Leporrier J, et al. Chemotherapy does not impair hypertrophy of the left liver after right portal vein obstruction. J Gastrointest Surg 2006;10:365-370
-
(2006)
J Gastrointest Surg
, vol.10
, pp. 365-370
-
-
Goere, D.1
Farges, O.2
Leporrier, J.3
-
21
-
-
0033637804
-
Preoperative systemic 5-fluorouracil does not increase the risk of liver resection
-
Parc Y, Dugué L, Farges O, Hiramatsu K, et al. Preoperative systemic 5-fluorouracil does not increase the risk of liver resection. Hepatogastroenterology 2000;47:1703-1705
-
(2000)
Hepatogastroenterology
, vol.47
, pp. 1703-1705
-
-
Parc, Y.1
Dugué, L.2
Farges, O.3
Hiramatsu, K.4
-
22
-
-
13444274825
-
Neoadjuvant chemotherapy does not increase postoperative complication rate after resection of colorectal liver metastases
-
Yedibela S, Elad L, Wein A, et al. Neoadjuvant chemotherapy does not increase postoperative complication rate after resection of colorectal liver metastases. Eur J Surg Oncol 2005;31:141-146
-
(2005)
Eur J Surg Oncol
, vol.31
, pp. 141-146
-
-
Yedibela, S.1
Elad, L.2
Wein, A.3
-
23
-
-
33750957147
-
Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases
-
Aloia T, Sebagh M, Fiasse M, et al. Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J Clin Oncol 2006;24:4983-4990
-
(2006)
J Clin Oncol
, vol.24
, pp. 4983-4990
-
-
Aloia, T.1
Sebagh, M.2
Fiasse, M.3
-
24
-
-
33846309211
-
Chemotherapy for colorectal cancer prior to liver resection for colorectal cancer hepatic metastases does not adversely affect peri-operative outcomes
-
Sahajpal A, Vollmer CM, Dixon E, et al. Chemotherapy for colorectal cancer prior to liver resection for colorectal cancer hepatic metastases does not adversely affect peri-operative outcomes. J Surg Oncol 2007;95:22-27
-
(2007)
J Surg Oncol
, vol.95
, pp. 22-27
-
-
Sahajpal, A.1
Vollmer, C.M.2
Dixon, E.3
-
25
-
-
33846641607
-
Preoperative chemotherapy and the outcome of liver resection for colorectal metastases
-
Hewes JC, Dighe S, Morris RW, et al. Preoperative chemotherapy and the outcome of liver resection for colorectal metastases. World J Surg 2007;31:353-364
-
(2007)
World J Surg
, vol.31
, pp. 353-364
-
-
Hewes, J.C.1
Dighe, S.2
Morris, R.W.3
-
26
-
-
34347234594
-
Preoperative chemotherapy for colorectal liver metastases: Impact on hepatic histology and postoperative outcome
-
Pawlik TM, Olino K, Gleisner AL, et al. Preoperative chemotherapy for colorectal liver metastases: impact on hepatic histology and postoperative outcome. J Gastrointest Surg 2007;11:860-868
-
(2007)
J Gastrointest Surg
, vol.11
, pp. 860-868
-
-
Pawlik, T.M.1
Olino, K.2
Gleisner, A.L.3
-
27
-
-
33846603686
-
Lack of evidence for increased operative morbidity after hepatectomy with perioperative use of bevacizumab: A matched case-control study
-
D'Angelica M, Kornprat P, Gonen M, et al. Lack of evidence for increased operative morbidity after hepatectomy with perioperative use of bevacizumab: a matched case-control study. Ann Surg Oncol 2007;14:759-765
-
(2007)
Ann Surg Oncol
, vol.14
, pp. 759-765
-
-
D'Angelica, M.1
Kornprat, P.2
Gonen, M.3
-
28
-
-
10744231437
-
Impact of steatosis on perioperative outcome following hepatic resection
-
Kooby DA, Fong Y, Suriawinata A, et al. Impact of steatosis on perioperative outcome following hepatic resection. J Gastrointest Surg 2003;7:1034-1044
-
(2003)
J Gastrointest Surg
, vol.7
, pp. 1034-1044
-
-
Kooby, D.A.1
Fong, Y.2
Suriawinata, A.3
-
29
-
-
0033922244
-
Seven hundred forty-seven hepatectomies in the 1990s: An update to evaluate the actual risk of liver resection
-
Belghiti J, Hiramatsu K, Benoist S, et al. Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg 2000;191:38-46
-
(2000)
J Am Coll Surg
, vol.191
, pp. 38-46
-
-
Belghiti, J.1
Hiramatsu, K.2
Benoist, S.3
-
30
-
-
36348974014
-
Steatosis predicts postoperative morbidity following hepatic resection for colorectal metastasis
-
Gomez D, Malik HZ, Bonney GK, et al. Steatosis predicts postoperative morbidity following hepatic resection for colorectal metastasis. Br J Surg 2007;94:1395-1402
-
(2007)
Br J Surg
, vol.94
, pp. 1395-1402
-
-
Gomez, D.1
Malik, H.Z.2
Bonney, G.K.3
-
31
-
-
0031781467
-
Demonstration of hepatic steatosis by computerized tomography in patients receiving 5-fluorouracil-based therapy for advanced colorectal cancer
-
Peppercorn PD, Reznek RH, Wilson P, et al. Demonstration of hepatic steatosis by computerized tomography in patients receiving 5-fluorouracil-based therapy for advanced colorectal cancer. Br J Cancer 1998;77:2008-2011
-
(1998)
Br J Cancer
, vol.77
, pp. 2008-2011
-
-
Peppercorn, P.D.1
Reznek, R.H.2
Wilson, P.3
-
32
-
-
0029038552
-
Reversible hepatic steatosis in patients treated with Interferon alfa-2a and 5-fluorouradl
-
Sorensen P, Edal AL, Madsen EL, et al. Reversible hepatic steatosis in patients treated with Interferon alfa-2a and 5-fluorouradl. Cancer 1995;75:2592-2596
-
(1995)
Cancer
, vol.75
, pp. 2592-2596
-
-
Sorensen, P.1
Edal, A.L.2
Madsen, E.L.3
-
33
-
-
0027424043
-
Hepatic toxicity associated with fluorouracil plus levamisole adjuvant therapy
-
Moertel CG, Fleming TR, Macdonald JS, et al. Hepatic toxicity associated with fluorouracil plus levamisole adjuvant therapy. J Clin Oncol 1993;11:2386-2390
-
(1993)
J Clin Oncol
, vol.11
, pp. 2386-2390
-
-
Moertel, C.G.1
Fleming, T.R.2
Macdonald, J.S.3
-
34
-
-
0023552434
-
Veno-occlusive disease of the liver following bone marrow transplantation
-
Jones RJ, Lee KS, Beschorner WE, et al. Veno-occlusive disease of the liver following bone marrow transplantation. Transplantation 1987;44:778-783
-
(1987)
Transplantation
, vol.44
, pp. 778-783
-
-
Jones, R.J.1
Lee, K.S.2
Beschorner, W.E.3
-
35
-
-
0036899613
-
Hepatic veno-occlusive disease in blood and bone marrow transplantation in children and young adults: Incidence, risk factors, and outcome in a cohort of 241 patients
-
Reiss U, Cowan M, McMillan A, et al. Hepatic veno-occlusive disease in blood and bone marrow transplantation in children and young adults: incidence, risk factors, and outcome in a cohort of 241 patients. J Pediatr Hematol Oncol 2002;24:746-750
-
(2002)
J Pediatr Hematol Oncol
, vol.24
, pp. 746-750
-
-
Reiss, U.1
Cowan, M.2
McMillan, A.3
-
36
-
-
0022485314
-
Hepatic lobar atrophy following obstruction of the ipsilateral portal vein from hilar cholangiocarcinoma
-
Takayasu K, Muramatsu Y, Shima Y, et al. Hepatic lobar atrophy following obstruction of the ipsilateral portal vein from hilar cholangiocarcinoma. Radiology 1986;160:389-393
-
(1986)
Radiology
, vol.160
, pp. 389-393
-
-
Takayasu, K.1
Muramatsu, Y.2
Shima, Y.3
-
37
-
-
0025255473
-
Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: A preliminary report
-
Makuuchi M, Thai BL, Takayasu K, et al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery 1990;107:521-527
-
(1990)
Surgery
, vol.107
, pp. 521-527
-
-
Makuuchi, M.1
Thai, B.L.2
Takayasu, K.3
-
38
-
-
0034126372
-
Resection of non-resectable liver metastases from colorectal cancer after percutaneous portal vein embolization
-
Azoulay D, Castaing D, Smail A, et al. Resection of non-resectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg 2000;231:480-486
-
(2000)
Ann Surg
, vol.231
, pp. 480-486
-
-
Azoulay, D.1
Castaing, D.2
Smail, A.3
-
39
-
-
33748931490
-
Improving resectability of hepatic colorectal metastases: Expert consensus statement
-
Abdalla EK, Adam R, Bilchik AJ, et al. Improving resectability of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol 2006;13:1271-1280
-
(2006)
Ann Surg Oncol
, vol.13
, pp. 1271-1280
-
-
Abdalla, E.K.1
Adam, R.2
Bilchik, A.J.3
-
40
-
-
0030710208
-
Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors
-
Kubota K, Makuuchi M, Kusaka K, et al. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology 1997;26:1176-1181
-
(1997)
Hepatology
, vol.26
, pp. 1176-1181
-
-
Kubota, K.1
Makuuchi, M.2
Kusaka, K.3
-
41
-
-
0032965124
-
Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume
-
Shirabe K, Shimada M, Gion T, et al. Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume. J Am Coll Surg 1999;188:304-309
-
(1999)
J Am Coll Surg
, vol.188
, pp. 304-309
-
-
Shirabe, K.1
Shimada, M.2
Gion, T.3
-
42
-
-
46949101878
-
-
Bouzari H, Amisano M, Zorzi D, et al. Hypertrophy of the future liver remnant following portal vein occlusion: portal vein embolization vs portal vein ligation. HPB 2006;8(suppl 2):27-28
-
Bouzari H, Amisano M, Zorzi D, et al. Hypertrophy of the future liver remnant volume following portal vein occlusion: portal vein embolization vs portal vein ligation. HPB 2006;8(suppl 2):27-28
-
-
-
-
43
-
-
46149095353
-
Right portal vein ligation is as efficient as portal vein embolization to induce hypertrophy of the left liver remnant
-
Aussilhou B, Lesurtel M, Sauvanet A, et al. Right portal vein ligation is as efficient as portal vein embolization to induce hypertrophy of the left liver remnant. J Gastrointest Surg 2008;12:297-303
-
(2008)
J Gastrointest Surg
, vol.12
, pp. 297-303
-
-
Aussilhou, B.1
Lesurtel, M.2
Sauvanet, A.3
-
44
-
-
46949097677
-
-
Gruenberger T, Tamandl D, Puhalla H, et al. Bevacizumab plus XELOX as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer. 2007 ASCO Annual Meeting Proceedings Part I. J Clin Oncol 2007; 25(suppl):4064
-
Gruenberger T, Tamandl D, Puhalla H, et al. Bevacizumab plus XELOX as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer. 2007 ASCO Annual Meeting Proceedings Part I. J Clin Oncol 2007; 25(suppl):4064
-
-
-
-
45
-
-
0027471469
-
Early use of cisplatin is safe after partial hepatectomy
-
Engum SA, Sidner RA, Miller GA, et al. Early use of cisplatin is safe after partial hepatectomy. J Pediatr Surg 1993; 28:411-417
-
(1993)
J Pediatr Surg
, vol.28
, pp. 411-417
-
-
Engum, S.A.1
Sidner, R.A.2
Miller, G.A.3
|